Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC network

Blood (2022) 139 (5): 792–796.

https://doi.org/10.1182/blood.2021012932

Published: 2022

Includes: Supplemental data

Journal Articles

High frequency of clonal hematopoiesis in Erdheim-Chester disease

Fleur Cohen Aubart, Damien Roos-Weil, Marine Armand, Alice Marceau-Renaut, Jean-François Emile, Nicolas Duployez, Frédéric Charlotte, Stéphanie Poulain, Raphael Lhote, Zofia Hélias-Rodzewicz, Véronique Della-Valle, Olivier Bernard, Karim Maloum, Florence Nguyen-Khac, Jean Donadieu, Zahir Amoura, Omar Abdel-Wahab, Julien Haroche

Blood (2021) 137 (4): 485–492.

https://doi.org/10.1182/blood.2020005101

Published: 2021

Includes: Supplemental data

Journal Articles

Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma

Blood (2020) 135 (20): 1811–1815.

https://doi.org/10.1182/blood.2019003073

Published: 2020

Journal Articles

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

Blood (2019) 134 (21): 1821–1831.

https://doi.org/10.1182/blood.2019001187

Published: 2019

Includes: Supplemental data

Journal Articles

Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group

Blood (2018) 132 (Supplement 1): 943.

https://doi.org/10.1182/blood-2018-99-115085

Published: 2018

Journal Articles

Clonal Hematopoiesis in Erdheim-Chester Disease

Julien Haroche, MD PhD, Stéphanie Poulain, MD PhD, Alice Marceau-Renaut, PharmD, Aline Renneville, Catherine Settegrana, Karim Maloum, Damien Roos-Weil, Florence Nguyen-Khac, MD PhD, Jean Donadieu, MD, Jean-François Emile, MD PhD, Zahir Amoura, Fleur Cohen-Aubart, MD PhD

Blood (2017) 130 (Supplement 1): 3788.

https://doi.org/10.1182/blood.V130.Suppl_1.3788.3788

Published: 2017

Journal Articles

B-Cell Prolymphocytic Leukemia, a Rare Lymphoproliferative Disorder: Analysis of 35 Cases, a Study on Behalf of the French Innovative Leukemia Organization (FILO)

Caroline Algrin, Elise Chapiro, Justine Saviellis, Anne Quinquenel, Anne-Sophie Michallet, MD PhD, David Ghez, MD PhD, Pierre Feugier, MD, Annie Brion, Cecile Tomowiak, MD, Luc-Matthieu Fornecker, Remy Gressin, MD, Laurent Sutton, MD, Karim Maloum, Catherine Settegrana, Lucile Baseggio, MD, Quentin Vincent, Florence Nguyen-Khac, MD PhD, Véronique Leblond

Blood (2017) 130 (Supplement 1): 4310.

https://doi.org/10.1182/blood.V130.Suppl_1.4310.4310

Published: 2017

Journal Articles

Clonal Evolution in CLL

Simon Bouzy, Marine Armand, Clementine Gabillaud, Elise Chapiro, Nadia Bougacha, Fotini Kostopoulou, PhD, Frederic Davi, MD PhD, Magali Le Garff-Tavernier, Karim Maloum, Veronique Leblond, Veronique Morel, Damien Roos-Weil, Anne Lavaud, Jean Gabarre, Choquet Sylvain, Santos Susin, Olivier Bernard, Florence Nguyen-Khac, MD PhD

Blood (2017) 130 (Supplement 1): 3008.

https://doi.org/10.1182/blood.V130.Suppl_1.3008.3008

Published: 2017

Journal Articles

Temozolomide in Relapse/Refractory Primary Vitreo-Retinal Lymphoma (R/R PVRL): A New Effective, Well-Tolerated and Cheap Reference. Result of a Study on Behalf of the LOC Network

Choquet Sylvain, Marine Baron, Anne Lavaud, Carole Soussain, MD PhD, Valerie Touitou, MD PhD, Christine Fardeau, Nathalie Cassoux, MD PhD, Magali Le Garff-Tavernier, Mirto Costopoulos, Caroline Houillier, MD, Karim Maloum, Véronique Leblond, Emmanuel Gyan, MDPhD, Pierre Soubeyran, MD PhD

Blood (2017) 130 (Supplement 1): 2845.

https://doi.org/10.1182/blood.V130.Suppl_1.2845.2845

Published: 2017

Journal Articles

The Gain of the Short Arm of Chromosome 2 (2pgain) Plays an Important Role in CLL Drug Resistance, and Has to be Systematically Considered before Deciding an Adapted Therapy

Fotini Kostopoulou, PhD, Nadia Bougacha, Clementine Gabillaud, Elise Chapiro, Simon Bouzy, Magali Le Garff-Tavernier, Pharm, PhD, Karim Maloum, Choquet Sylvain, Veronique Leblond, Jean Gabarre, Anne Lavaud, Veronique Morel, Damien Roos-Weil, Madalina Uzunov, Romain Guieze, MD PhD, Olivier Tournilhac, MD PhD, Santos Susin, Olivier Bernard, Florence Nguyen-Khac, MD PhD

Blood (2017) 130 (Supplement 1): 1729.

https://doi.org/10.1182/blood.V130.Suppl_1.1729.1729

Published: 2017

Journal Articles

The Gain of the Short Arm of Chromosome 2 (2p+) Induces XPO1 Overexpression and Drug Resistance in Chronic Lymphocytic Leukemia

Blood (2015) 126 (23): 492.

https://doi.org/10.1182/blood.V126.23.492.492

Published: 2015

Journal Articles

To Dose or Not to Dose: Are IL-10 and IL-6 Accurate Biomarkers to Detect Leptomeningeal Involvement in Small B-Cell Lymphoproliferation?

Rathana Kim, Myrto Costopoulos, PharmD, Sylvain Choquet, MD, Karim Maloum, MD PhD, Caroline Algrin, MD, Khe Hoang-Xuan, MD PhD, Catherine Settegrana, PharmD, Juliette Villemonteix, Martine Brissard, Frederic Davi, MD PhD, Veronique Leblond, MD PhD, Helene Merle-Beral, MD PhD, Magali Le Garff-Tavernier, PharmD, PhD

Blood (2015) 126 (23): 3878.

https://doi.org/10.1182/blood.V126.23.3878.3878

Published: 2015

Journal Articles

NOTCH1 Mutations Are Associated With The 14q Deletion In Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Blood (2013) 122 (21): 2561.

https://doi.org/10.1182/blood.V122.21.2561.2561

Published: 2013

Journal Articles

Sex Chromosome Loss May Represent a Disease-Associated Clonal Population in Chronic Lymphocytic Leukemia (CLL),

Iléana Antony-Debré, Nathalie Marchay, Christophe Parizot, Elise Chapiro, Ong Anh Cung, Stéphanie Mathis, Aurore Grelier, Karim Maloum, MD, PhD, Sylvain Choquet, MD, Frederic Davi, Zahia Azgui, Madalina Uzunov, Veronique Leblond, Hélène Merle-Beral, Laurent Sutton, Florence Nguyen-Khac, MD, PhD

Blood (2011) 118 (21): 3534.

https://doi.org/10.1182/blood.V118.21.3534.3534

Published: 2011

Journal Articles

Long-Term Outcome of B-CLL Patients Treated in a Prospective Trial Evaluating Combination of Oral Fludarabine and Cyclophosphamide As Frontline Therapy

Romain Guièze, MD, Olivier Tournilhac, MD, PhD, Karim Maloum, MD, PhD, Stéphane Leprêtre, MD, Corinne Haioun, Pierre Feugier, MD, PhD, Alain Delmer, MD, Michel Leporrier, MD, Bruno Cazin, MD

Blood (2011) 118 (21): 1795.

https://doi.org/10.1182/blood.V118.21.1795.1795

Published: 2011

Journal Articles

Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC

Blood (2011) 117 (23): 6109–6119.

https://doi.org/10.1182/blood-2010-11-317073

Published: 2011

Journal Articles

Specific Chromosomal IG Translocations Have Different Prognosis In Chronic Lymphocytic Leukemia

Blood (2010) 116 (21): 582.

https://doi.org/10.1182/blood.V116.21.582.582

Published: 2010

Journal Articles

Autologous Stem Cell Transplantation (ASCT) in CLL. Results of a Phase III Randomized Multicenter Trial.

Blood (2009) 114 (22): 878.

https://doi.org/10.1182/blood.V114.22.878.878

Published: 2009

Journal Articles

Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis

Ronan Chaligné, Chloé James, Carole Tonetti, Rodolphe Besancenot, Jean Pierre Le Couédic, Fanny Fava, Fréderic Mazurier, Isabelle Godin, Karim Maloum, Frédéric Larbret, Yann Lécluse, William Vainchenker, Stéphane Giraudier

Blood (2007) 110 (10): 3735–3743.

https://doi.org/10.1182/blood-2007-05-089003

Published: 2007

Journal Articles

Evaluation of Minimal Residual Disease in Blood and Bone Marrow for CLL as Assessed by 6 Color Flow Cytometry.

Karim Maloum, MD, PhD, Laurent Sutton, MD, Magali Le Garff-Tavernier, MD, Caroline Fiocconi, MD, Patrick Bonnemye, Martine Brissard, Helene Merle-Beral, MDPhD

Blood (2006) 108 (11): 2793.

https://doi.org/10.1182/blood.V108.11.2793.2793

Published: 2006

NARROW

CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC network

High frequency of clonal hematopoiesis in Erdheim-Chester disease

Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group

Clonal Hematopoiesis in Erdheim-Chester Disease

B-Cell Prolymphocytic Leukemia, a Rare Lymphoproliferative Disorder: Analysis of 35 Cases, a Study on Behalf of the French Innovative Leukemia Organization (FILO)

Clonal Evolution in CLL

Temozolomide in Relapse/Refractory Primary Vitreo-Retinal Lymphoma (R/R PVRL): A New Effective, Well-Tolerated and Cheap Reference. Result of a Study on Behalf of the LOC Network

The Gain of the Short Arm of Chromosome 2 (2pgain) Plays an Important Role in CLL Drug Resistance, and Has to be Systematically Considered before Deciding an Adapted Therapy

The Gain of the Short Arm of Chromosome 2 (2p+) Induces XPO1 Overexpression and Drug Resistance in Chronic Lymphocytic Leukemia

To Dose or Not to Dose: Are IL-10 and IL-6 Accurate Biomarkers to Detect Leptomeningeal Involvement in Small B-Cell Lymphoproliferation?

NOTCH1 Mutations Are Associated With The 14q Deletion In Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Sex Chromosome Loss May Represent a Disease-Associated Clonal Population in Chronic Lymphocytic Leukemia (CLL),

Long-Term Outcome of B-CLL Patients Treated in a Prospective Trial Evaluating Combination of Oral Fludarabine and Cyclophosphamide As Frontline Therapy

Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC

Specific Chromosomal IG Translocations Have Different Prognosis In Chronic Lymphocytic Leukemia

Autologous Stem Cell Transplantation (ASCT) in CLL. Results of a Phase III Randomized Multicenter Trial.

Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis

Evaluation of Minimal Residual Disease in Blood and Bone Marrow for CLL as Assessed by 6 Color Flow Cytometry.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only